AST SpaceMobile (ASTS) stock slides today as AT&T sets satellite beta timeline; insider buy filing in focus
1 January 2026
2 mins read

AST SpaceMobile (ASTS) stock slides today as AT&T sets satellite beta timeline; insider buy filing in focus

NEW YORK, December 31, 2025, 18:14 ET — After-hours

  • AST SpaceMobile shares fell 2.7% at the close and edged up about 0.5% in after-hours trade. 1
  • AT&T said it has brought a fourth satellite “ground gateway” online and plans a limited beta satellite service in the first half of 2026. 2
  • A regulatory filing showed AST director Keith Larson bought 625 shares at $80 per share under a pre-arranged trading plan. 3

Shares of AST SpaceMobile fell 2.7% on Wednesday, pulling back after a 4.5% rise a day earlier, as traders weighed new partner and regulatory signals into year-end positioning. 4

The pullback matters because AST SpaceMobile has become one of the market’s more volatile ways to bet on “direct-to-device” connectivity — using satellites to connect to standard, unmodified smartphones when users are outside cell-tower range. 1

AT&T’s latest update put fresh attention on the near-term buildout needed for service, including ground infrastructure and a limited beta program. That timeline is a key marker for investors trying to pin down when AST’s constellation can move from demonstrations to broader commercial use. 2

ASTS closed at $72.63 and was up about 0.5% at roughly $73.00 in after-hours trading. The shares traded between $71.61 and $75.50 during the regular session. 1

About 10.4 million shares changed hands, below the stock’s 30-day average volume of about 13.75 million, data showed. 1

In a blog post dated Dec. 29, AT&T said it has brought its fourth “ground gateway” online — a ground station that links satellite traffic into the carrier’s terrestrial network — and positioned the gateways to maximize coverage and performance. 2

Robert Walters, AT&T’s senior vice president for network planning, wrote that “we plan to offer a select number of AT&T customers and public safety on FirstNet beta satellite service in the first half of next year,” referring to FirstNet, AT&T’s network for first responders. 2

Walters also said AST has announced it is on track to complete four more launches by March 2026, a timetable investors have been using to track progress toward broader coverage. 2

A Form 4 filing showed AST director Keith Larson bought 625 shares of Class A common stock at $80 per share on Dec. 24, held indirectly via an IRA. The filing said the transaction was executed under a Rule 10b5-1 plan adopted in September — a pre-set trading plan that can limit how much discretion an insider has over timing. 3

The stock also drew attention after Levi & Korsinsky said on Tuesday it had commenced an investigation of AST SpaceMobile concerning possible violations of federal securities laws. 5

AST operates in a competitive satellite-communications landscape that includes SpaceX’s Starlink and Globalstar, which are also working on low-Earth-orbit networks aimed at extending mobile connectivity beyond tower coverage. Zacks Equity Research, writing on Nasdaq.com, flagged AST’s “premium valuation” and said richly valued stocks can be sensitive to broader macro swings. 6

The Nasdaq Composite fell about 0.8% on Wednesday, which weighed on growth shares broadly. ASTS’ 52-week range of $17.51 to $102.79 underscores how quickly sentiment has shifted around the sector’s “space-to-phone” theme. 1

U.S. equity markets will be closed on Thursday for New Year’s Day and reopen on Friday, Jan. 2. Traders will be watching for firmer details on launch timing, network readiness and the path from beta testing to commercial rollout. 7

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
IREN stock ends 2025 lower as bitcoin slips — what traders watch next
Previous Story

IREN stock ends 2025 lower as bitcoin slips — what traders watch next

IBM stock slides after-hours on year-end pullback as investors eye Jan. 28 earnings
Next Story

IBM stock slides after-hours on year-end pullback as investors eye Jan. 28 earnings

Go toTop